171 related articles for article (PubMed ID: 8027412)
1. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression.
Tollefson GD; Rampey AH; Beasley CM; Enas GG; Potvin JH
J Clin Psychopharmacol; 1994 Jun; 14(3):163-9. PubMed ID: 8027412
[TBL] [Abstract][Full Text] [Related]
2. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.
Goldstein DJ; Rampey AH; Potvin JH; Masica DN; Beasley CM
J Clin Psychiatry; 1993 Aug; 54(8):309-16. PubMed ID: 8253699
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
4. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
Tollefson GD; Sayler ME
Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between fluoxetine and suicidality in bulimia nervosa.
Wheadon DE; Rampey AH; Thompson VL; Potvin JH; Masica DN; Beasley CM
J Clin Psychiatry; 1992 Jul; 53(7):235-41. PubMed ID: 1639742
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
[TBL] [Abstract][Full Text] [Related]
7. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
8. Suicidality and fluoxetine: is there a relationship?
Fava M; Rosenbaum JF
J Clin Psychiatry; 1991 Mar; 52(3):108-11. PubMed ID: 2005073
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine: activating and sedating effects.
Beasley CM; Potvin JH
Int Clin Psychopharmacol; 1993; 8(4):271-5. PubMed ID: 8277147
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
[TBL] [Abstract][Full Text] [Related]
11. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
12. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
Akiskal HS; Benazzi F
J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
Tollefson GD; Fawcett J; Winokur G; Beasley CM; Potvin JH; Faries DE; Rampey AH; Sayler ME
Ann Clin Psychiatry; 1993 Dec; 5(4):209-24. PubMed ID: 8312978
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxine.
Tourian KA; Padmanabhan K; Groark J; Ninan PT
J Clin Psychopharmacol; 2010 Aug; 30(4):411-6. PubMed ID: 20631558
[TBL] [Abstract][Full Text] [Related]
15. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine: activating and sedating effects at multiple fixed doses.
Beasley CM; Sayler ME; Weiss AM; Potvin JH
J Clin Psychopharmacol; 1992 Oct; 12(5):328-33. PubMed ID: 1479050
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine.
Dittmann RW; Linden M; Osterheider M; Schaaf B; Ohnmacht U; Weber HJ
Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):28-34. PubMed ID: 9035225
[TBL] [Abstract][Full Text] [Related]
18. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
19. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?
Berk M; Dodd S
Med Hypotheses; 2005; 65(1):39-43. PubMed ID: 15893115
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
